Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002102834A3 Synthetic sensor peptide for the detection and/or measurement of kinase or phosphate activity of proteins
11/20/2003WO2002101045A3 Vanilloid receptor-related nucleic acids and polypeptides
11/20/2003WO2002099982A3 Methods for improving signal detection from an array
11/20/2003WO2002093125A3 Micromagnetic systems and methods for microfluidics
11/20/2003WO2002092218A3 Surf2lead
11/20/2003WO2002090544A3 Protein-protein interactions in adipocyte cells (3)
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002088396A3 Reagents and methods for automated in situ or microarray hybridization
11/20/2003WO2002088181A3 Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
11/20/2003WO2002086071A3 Cancer-testis antigens
11/20/2003WO2002086051A3 Nucleic acid analysis by mass differentiable oligomers
11/20/2003WO2002083942A3 Method and device for determining and selecting molecule-molecule interactions
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002081642A3 Gene brcc-3 and diagnostic and therapeutic uses thereof
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002077293A3 Detection of fungal pathogens using the polymerase chain reaction
11/20/2003WO2002072825A3 Human mrp5-like protein
11/20/2003WO2002072588A9 Photo-induced electron transfer fluorescent sensor molecules
11/20/2003WO2002070703A8 Cell visual characteristic-modifying sequences
11/20/2003WO2002070658A3 Compositions and methods for increasing amino acid absorption in mammals
11/20/2003WO2002064734A3 Identification of target-specific folding sites in peptides and proteins
11/20/2003WO2002064556A8 Complex carbohydrate arrays and methods for the manufacture and uses thereof
11/20/2003WO2002063306A3 Use of high density microparticles for removal of pathogens
11/20/2003WO2002061121A3 Methods of analysis of nucleic acids
11/20/2003WO2002057794A3 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
11/20/2003WO2002057416A8 Improved biochip
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003WO2002052015A3 Self-replicating rna molecule from hepatitis c virus
11/20/2003WO2002046767A3 Diagnosis and treatment of alzheimer's disease
11/20/2003WO2002044417A9 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/20/2003WO2002038744A3 Proteases
11/20/2003WO2002036624A9 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof
11/20/2003WO2002034953A9 Detection and quantification of human herpes viruses
11/20/2003WO2002031478A8 Methods and devices for assays using analyte-binding partners
11/20/2003WO2002024942A8 Adp-glucose receptor
11/20/2003WO2002022886A3 Expression of genes in diabetes mellitus and insulin resistance
11/20/2003WO2002012897A3 Automated information processing in randomly ordered arrays
11/20/2003WO2002008765A3 Basal cell markers in breast cancer and uses thereof
11/20/2003WO2002008469A9 Methods, systems, and articles of manufacture for evaluating biological data
11/20/2003WO2002006829A3 A process for discriminating between biological states based on hidden patterns from biological data
11/20/2003WO2002002055A3 Antifungal compounds and methods of use
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003WO2001085334A3 Chemical structure identification
11/20/2003WO2001081541A3 Pcr-hybridization assays specific for integrated retroviruses
11/20/2003US20030217379 Defective tyrosine phosphatase animal model for diagnosing and treating diabetes and eating disorders
11/20/2003US20030217372 Methods of using alpha 1b-adrenergic receptors
11/20/2003US20030217371 Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors
11/20/2003US20030216875 Device for measuring a food physicality and method for measuring the same
11/20/2003US20030216871 Calculating a characteristic property of a molecule by correlation analysis
11/20/2003US20030216869 Computer code for portable sensing
11/20/2003US20030216867 Methods and systems for molecular modeling
11/20/2003US20030216829 Log cutting procedures
11/20/2003US20030216660 Breath test apparatus and methods
11/20/2003US20030216562 Genetic engineered polypeptides; binding to antibodies; recovering culture product
11/20/2003US20030216561 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030216559 Medical diagnosis using polypeptide; amplification, determination, calibration; monitoring immunotherapy
11/20/2003US20030216558 Novel compositions and methods for cancer
11/20/2003US20030216544 Methods and reagents for diagnosis of autoantibodies
11/20/2003US20030216445 Osteoporosis; immunosuppressants; wound healing agent
11/20/2003US20030216379 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/20/2003US20030216318 Inhibition of transmission of tick-borne infections
11/20/2003US20030216305 Identification and characterization of a polypeptide having homology to the sarcoma-amplified protein SAS
11/20/2003US20030216288 Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules
11/20/2003US20030216286 Methods and compositions for inhibiting angiogenesis
11/20/2003US20030216237 Bio cell cleaning centrifuge having detachable chamber body
11/20/2003US20030215959 Contacting complex comprising receptor and quinoxaline derivative ligand bound thereto with test compound, yielding a receptor-test compound complex and free quinoxaline derivative and measuring amount of free quinoxaline derivative generated
11/20/2003US20030215952 Tests for the rapid evaluation of ischemic states and kits
11/20/2003US20030215951 Determining leukocyte concentration in fluids using colorimetric analysis; diagnosing mastitis; veterinary medicine
11/20/2003US20030215937 Conductive microplate
11/20/2003US20030215919 Phosphodiesterase 8A
11/20/2003US20030215917 Compositions and methods for quantification of extent of replication of Hepatitis C viral genome in an in vitro tissue culture system, in particular, replicon assay for identifying drug substances in high throughput screening format
11/20/2003US20030215912 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis
11/20/2003US20030215911 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215910 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2003US20030215904 Comprises membrane protein for treatment and diagnosis of cell proliferative disorders; antitumor/anticarcinogenic agents
11/20/2003US20030215903 Nanostructures containing PNA joining or functional elements
11/20/2003US20030215901 Method for screening compounds useful as UV protectant filters for providing protection to biological systems
11/20/2003US20030215900 Diagnosing prostate cancer, arthritis and ulcerative disorders; tissue engineering; wound healing agents
11/20/2003US20030215898 Methods for using 22045, a human cyclic nucleotide phosphodiesterase
11/20/2003US20030215897 Purifying target proteins using post-synaptic density 95, discs-large and zonular occludens (PDZ1) domain and a no receptor potential A (NorpA) sequence soluble matrix
11/20/2003US20030215894 Protein-induced monoclonal receptors to protein ligands
11/20/2003US20030215893 Nucleic acids, proteins, and antibodies
11/20/2003US20030215892 Multidimensional leukocyte differential analysis
11/20/2003US20030215891 High throughput assays
11/20/2003US20030215890 Fixing and sphering cells for assays and analysis of body fluid samples such as blood and cerebrospinal fluid; diagnosing cancer, immunological and nervous system disorders
11/20/2003US20030215889 Membrane preparation comprising calcium channel transport protein for screening and identifying modulator of ion transport; for prevention and treatment of nervous tissue injuries and diabetes
11/20/2003US20030215888 Genetically engineered myoblast for identifying antiproliferative agents; antiapoptosis; drug screening
11/20/2003US20030215887 Methods of testing for agonists and antagonists of cell surface receptors
11/20/2003US20030215886 Diagnosing kidney rejection via identification of organ rejection marker in urine; anti-rejection drugs; immunosuppressants
11/20/2003US20030215885 Using presence of antibody complex to diagnose inflammatory diseases; antiiflammatory agents; immunoassay
11/20/2003US20030215884 Preparing membrane protein for treatment and prevention of parkinson's, alzheimer's and neurodegenerative diseases
11/20/2003US20030215881 Apparatus which use hemolysin to detect chemical warfare, pesticides and anticarcinogenic agents
11/20/2003US20030215880 Motif-grafted hybrid polypeptides and uses thereof
11/20/2003US20030215879 Comprise enzymatic polypeptide for use in the treatment of inflammation; aniinflammatory agents
11/20/2003US20030215877 Directed protein docking algorithm
11/20/2003US20030215876 Solid phase synthesis with benzylidene linker attaching compound on glass slide; microarrays; drug screening
11/20/2003US20030215875 Screening process for atopic dermatitis
11/20/2003US20030215872 Screening apparatus and method for making
1 ... 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 ... 3937